Archives

During the study period, there was an 11-fold increase in food allergy-related referrals

Recurrent urinary tract infections linked to decrease of up to 27 mL/min/1.73 m² in estimated glomerular filtration rate

Rifaximin monotherapy reduces risk for breakthrough OHE episode and results in a lower mortality rate than lactulose monotherapy

Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among CKD patients at risk for progression

Authors call for aggressively delabeling these patients to avoid treatment failure

Second study shows that only 14 percent of patients correctly identified symptoms requiring epinephrine

Significantly higher chance of experiencing delirium seen for those with worsening of their PSQI over three scores

Reduction of 75 and 77 percent seen in estimated mean monthly attack rate with 25-mg, 50-mg NTLA-2002 versus placebo

FAR was one of only two markers that were significant in predicting both PE and PE with severe features

Higher odds of hospital death, higher adjusted total cost, and longer hospital stays seen for patients with malnutrition